We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Merck & Co., Inc. stands seventh on our list and recently ...

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future ...

Merck opened a $1 billion facility at its North Carolina site last month to boost U.S. production. Merck to invest $1 billion in new Delaware plant to boost US manufacturing Skip to main content ...

Pipeline Depth: $50 Billion in Potential. While oncology contributes a significant part to Merck’s revenue, its top-selling drug will confront biosimilar challenges after 2028.Nevertheless ...

Merck beats Q1 2025 estimates despite Gardasil sales drop, driven by Vaxneuvance, Winrevair & Welireg. Click here to find out why MRK stock is a Strong Buy.

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the U.S. on October 1, and expects to hit peak adoption ...